Nephrotic Syndrome Clinical Trial
Official title:
Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome
The study aims to describe the biochemical coagulation profile and investigate the effect of Low molecular weight heparin and Apixaban on this profile in patients with nephrotic syndrome.
The initial part of the study is a prospective cross-sectional study which will describe the biochemical coagulation profile in nephrotic patients. It will include 60 patients with nephrotic syndrome and data from 50 anonymous blood donors matched in age and gender for comparison. The second part of the study is an open-label, controlled, non-randomized, interventional clinical trial consisting of 3 groups of patients with nephrotic syndrome or atrial fibrillation treated with either Dalteparin or Apixaban. The study participant is expected to be in stable condition after 4 full days of treatment. For administrative reasons, the final biochemical tests are performed on day 4, 5, 6 or 7 described as day 4 in this protocol. - Group A: Up to 50 patients with nephrotic syndrome treated with injection Dalteparin 200 Units/kg subcutaneous once a day for 4 days - Group B: 10 patients with nephrotic syndrome and membranous nephropathy treated with Apixaban 5 mg twice daily for 4 days. - Group C: 10 patients with atrial fibrillation and no kidney disease treated with Apixaban 5 mg twice daily for 4 days. Patients participating in the initial part of the study will be included in det second part (Group A) if they meet the inclusion criteria. If the patient is diagnosed with membranous nephropathy it is possible to be included in the initial part as well as the second part (Group A and B). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02238418 -
Efficacy of Usual Vitamin D Supplementation and Its Impact on Children and Adolescents Calciuria.
|
Phase 4 | |
Completed |
NCT01895894 -
Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic Syndrome
|
Phase 4 | |
Completed |
NCT01411982 -
Role of PACAP in Nehprotic Syndrome
|
N/A | |
Recruiting |
NCT00308321 -
Long Term Tapering or Standard Steroids for Nephrotic Syndrome
|
Phase 4 | |
Active, not recruiting |
NCT03326037 -
Study of The Association of Mutations in The NPHS2 Gene and Nephrotic Syndrome in Children and Adults in Middle East
|
||
Recruiting |
NCT01240564 -
The Nephrotic Syndrome Study Network (NEPTUNE)
|
N/A | |
Completed |
NCT01252901 -
Registry for Patients With Wilms' Tumor Suppressor Gene 1 (WT1) Mutation Associated Diseases
|
N/A | |
Completed |
NCT01197040 -
Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic Syndrome
|
Phase 3 | |
Terminated |
NCT00883636 -
Cardiomyopathy in Steroid-resistant Nephrotic Syndrome: Impact of Focal Segmental Glomerulosclerosis
|
N/A | |
Completed |
NCT00035334 -
Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis
|
Phase 2/Phase 3 | |
Terminated |
NCT00004466 -
Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic Syndrome
|
Phase 2 | |
Terminated |
NCT04558892 -
Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome.
|
Phase 2/Phase 3 | |
Completed |
NCT02257697 -
A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Refractory Nephrotic Syndrome
|
Phase 3 | |
Completed |
NCT00362531 -
Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome
|
Phase 2/Phase 3 | |
Completed |
NCT00289328 -
Glucocorticoid-induced Osteopenia in Children
|
N/A | |
Recruiting |
NCT04759274 -
Diuretic Tuner Clinical Decision Support
|
N/A | |
Completed |
NCT00001212 -
Drug Therapy in Lupus Nephropathy
|
Phase 2 | |
Recruiting |
NCT05623033 -
The Predictive Value of Dynamic Changes of CD4+T Lymphocytes in Primary Nephrotic Syndrome With Infection
|
||
Completed |
NCT03332420 -
The Efficacy of Huaiqihuang Granule in Children With Primary Nephrotic Syndrome
|
||
Not yet recruiting |
NCT05904197 -
Effectiveness of Educational Gamified Cards About Nephrotic Syndrome
|
N/A |